| Year |
Citation |
Score |
| 2012 |
Cabello CM, Lamore SD, Bair WB, Qiao S, Azimian S, Lesson JL, Wondrak GT. The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Investigational New Drugs. 30: 1289-301. PMID 21547369 DOI: 10.1007/S10637-011-9676-7 |
0.5 |
|
| 2011 |
Cabello CM, Lamore SD, Bair WB, Davis AL, Azimian SM, Wondrak GT. DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. Free Radical Research. 45: 276-92. PMID 21034357 DOI: 10.3109/10715762.2010.526766 |
0.412 |
|
| 2010 |
Bair WB, Cabello CM, Uchida K, Bause AS, Wondrak GT. GLO1 overexpression in human malignant melanoma. Melanoma Research. 20: 85-96. PMID 20093988 DOI: 10.1097/Cmr.0B013E3283364903 |
0.471 |
|
| 2010 |
Cabello CM, Qiao S, Bair WB, Davis AL, Lesson JL, Wondrak GT. GLO1 Downregulation in Human Renal Cell Carcinoma Enables Targeted Chemotherapeutic Intervention Using Methylglyoxal as Cytotoxic Heat Shock Inducer Free Radical Biology and Medicine. 49: S73-S74. DOI: 10.1016/J.Freeradbiomed.2010.10.184 |
0.327 |
|
| 2010 |
Cabello CM, Lamore SD, Bair WB, Davis AL, Lesson JL, Wondrak GT. Switching Enemies: The Redox Antimalarial Dihydroartemisinin Targets Human Metastatic Melanoma Cells but not Primary Melanocytes through Induction of NOXA-dependent Apoptosis Free Radical Biology and Medicine. 49: S73. DOI: 10.1016/J.Freeradbiomed.2010.10.183 |
0.422 |
|
| 2009 |
Cabello CM, Bair WB, Bause AS, Wondrak GT. Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1. Biochemical Pharmacology. 78: 344-54. PMID 19394313 DOI: 10.1016/J.Bcp.2009.04.016 |
0.477 |
|
| 2009 |
Cabello CM, Bair WB, Ley S, Lamore SD, Azimian S, Wondrak GT. The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines. Biochemical Pharmacology. 77: 1125-38. PMID 19186174 DOI: 10.1016/J.Bcp.2008.12.002 |
0.457 |
|
| 2009 |
Cabello CM, Bair WB, Lamore SD, Ley S, Bause AS, Azimian S, Wondrak GT. The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radical Biology & Medicine. 46: 220-31. PMID 19000754 DOI: 10.1016/J.Freeradbiomed.2008.10.025 |
0.424 |
|
| 2004 |
Mustacich D, Wagner A, Williams R, Bair W, Barbercheck L, Stratton SP, Bhattacharyya AK, Powis G. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse. Carcinogenesis. 25: 1983-9. PMID 15166090 DOI: 10.1093/Carcin/Bgh195 |
0.426 |
|
| 2002 |
Bair WB, Hart N, Einspahr J, Liu G, Dong Z, Alberts D, Bowden GT. Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 1645-52. PMID 12496056 |
0.304 |
|
| 1999 |
Kramer-Stickland K, Edmonds A, Bair WB, Bowden GT. Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation. Carcinogenesis. 20: 2137-42. PMID 10545417 DOI: 10.1093/Carcin/20.11.2137 |
0.343 |
|
| 1998 |
Barthelman M, Bair WB, Stickland KK, Chen W, Timmermann BN, Valcic S, Dong Z, Bowden GT. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis. 19: 2201-4. PMID 9886579 DOI: 10.1093/Carcin/19.12.2201 |
0.411 |
|
| Show low-probability matches. |